These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18525185)

  • 21. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
    Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
    Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.
    Tatsukawa H; Sano T; Fukaya Y; Ishibashi N; Watanabe M; Okuno M; Moriwaki H; Kojima S
    Mol Cancer; 2011 Jan; 10():4. PubMed ID: 21214951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
    Qin XY; Suzuki H; Honda M; Okada H; Kaneko S; Inoue I; Ebisui E; Hashimoto K; Carninci P; Kanki K; Tatsukawa H; Ishibashi N; Masaki T; Matsuura T; Kagechika H; Toriguchi K; Hatano E; Shirakami Y; Shiota G; Shimizu M; Moriwaki H; Kojima S
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4969-4974. PubMed ID: 29686061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
    Sun HC; Zhang W
    Ann Surg; 2008 May; 247(5):900; author reply 900-1. PubMed ID: 18438131
    [No Abstract]   [Full Text] [Related]  

  • 25. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
    Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
    Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of recurrent hepatocellular carcinoma with retinoid].
    Moriwaki H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1980-4. PubMed ID: 11791378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can a vitamin prevent hepatocellular carcinoma?
    Venook AP
    Hepatology; 1997 Jan; 25(1):249-50. PubMed ID: 8985300
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preventive use of retinoids for occurrence of liver neoplasm].
    Muto Y
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2032-7. PubMed ID: 8586927
    [No Abstract]   [Full Text] [Related]  

  • 29. [Postoperative interferon therapy after resection of hepatitis C virus-related hepatocellular carcinoma].
    Katagiri S; Tokushige K; Yamamoto M
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):795-801. PubMed ID: 18525184
    [No Abstract]   [Full Text] [Related]  

  • 30. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer.
    Abu J; Batuwangala M; Herbert K; Symonds P
    Lancet Oncol; 2005 Sep; 6(9):712-20. PubMed ID: 16129372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
    Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
    Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Towards a chemoprevention of hepatocellular carcinoma?].
    Ganne-Carrié N; Christidis C; Beaugrand M
    Gastroenterol Clin Biol; 1997; 21(6-7):447-9. PubMed ID: 9295970
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group.
    Muto Y; Moriwaki H; Ninomiya M; Adachi S; Saito A; Takasaki KT; Tanaka T; Tsurumi K; Okuno M; Tomita E; Nakamura T; Kojima T
    N Engl J Med; 1996 Jun; 334(24):1561-7. PubMed ID: 8628336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.
    Shao RX; Otsuka M; Kato N; Taniguchi H; Hoshida Y; Moriyama M; Kawabe T; Omata M
    Gastroenterology; 2005 Jan; 128(1):86-95. PubMed ID: 15633126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High risk group for development of hepatocellular carcinoma].
    Koike Y; Shiratori Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
    [No Abstract]   [Full Text] [Related]  

  • 37. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A; Costa A
    N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract]   [Full Text] [Related]  

  • 38. Summaries for patients. Does interferon-alpha prevent recurrence of malignant tumors in patients with hepatitis C - related liver cancer?
    Ann Intern Med; 2001 May; 134(10):S-7. PubMed ID: 11357861
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
    Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
    J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do we conquer the recurrence of HCC?
    Nouso K
    J Gastroenterol; 2015 Jun; 50(6):703-4. PubMed ID: 25330977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.